Robert Douglas Anderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert Douglas Anderson has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
Geoffrey Lee
Department of Cardiology, Royal Melbourne Hospital, Parkville, VIC, Australia
10 shared publications- Jonathan M. Kalman
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Baker Heart and Diabetes Institute, Melbourne, Australia
6 shared publications - Saurabh Kumar
Department of Cardiology, Westmead Hospital, Westmead Applied Research Centre, University of Sydney, Westmead, Australia
6 shared publications Troy Watts
Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Victoria, Australia
6 shared publications- Geoffrey Lee
Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Victoria, Australia
5 shared publications - Joshua Hawson
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia
4 shared publications
Latest Publications
- 16 January 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (3) , 554-560
Short‐Term Procedural Outcomes of Posterior Wall Isolation Using the Affera Pulse Field Ablation System
Background: Posterior wall isolation (PWI) is often added to pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF) and at redo ablation. Still, procedural performance with the Affera pulsed field ablation (PFA) platform is not well described. Methods: We retrospectively analyzed consecutive patients who underwent PWI with the Affera Sphere‐9 lattice‐tip catheter from April to August 2025. Baseline characteristics and procedural data, including PWI time, number of lesions, and acute success, were analyzed. The primary procedural endpoint was acute PWI success. Secondary measures included time to PWI, number of applications, posterior wall area isolated, and complications. Results: Forty patients underwent PWI (paroxysmal AF 13 [32.5%], persistent AF 27 [67.5%]). First pass PWI was achieved in 97.5%; overall acute PWI success was 100%. Median time to complete PWI was 7.0 min (IQR 5.1–11.0). Mean lesions for PWI were 19.6 ± 6.6, and the mean posterior wall area isolated was 12.9 ± 4.5 cm². Two minor vascular complications occurred (5.0%): one acute and one delayed femoral hematoma, both managed conservatively. After a median follow‐up of 76 [58.5–121] days, 38/40 (95%) patients remained free from atrial arrhythmia. Conclusions: PWI with the Affera Sphere‐9 system achieved 97.5% first‐pass isolation with rapid, consistent procedural times. Further study of lesion durability and clinical outcomes is warranted.
- 16 January 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (3) , 554-560
Short‐Term Procedural Outcomes of Posterior Wall Isolation Using the Affera Pulse Field Ablation System
Background: Posterior wall isolation (PWI) is often added to pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF) and at redo ablation. Still, procedural performance with the Affera pulsed field ablation (PFA) platform is not well described. Methods: We retrospectively analyzed consecutive patients who underwent PWI with the Affera Sphere‐9 lattice‐tip catheter from April to August 2025. Baseline characteristics and procedural data, including PWI time, number of lesions, and acute success, were analyzed. The primary procedural endpoint was acute PWI success. Secondary measures included time to PWI, number of applications, posterior wall area isolated, and complications. Results: Forty patients underwent PWI (paroxysmal AF 13 [32.5%], persistent AF 27 [67.5%]). First pass PWI was achieved in 97.5%; overall acute PWI success was 100%. Median time to complete PWI was 7.0 min (IQR 5.1–11.0). Mean lesions for PWI were 19.6 ± 6.6, and the mean posterior wall area isolated was 12.9 ± 4.5 cm². Two minor vascular complications occurred (5.0%): one acute and one delayed femoral hematoma, both managed conservatively. After a median follow‐up of 76 [58.5–121] days, 38/40 (95%) patients remained free from atrial arrhythmia. Conclusions: PWI with the Affera Sphere‐9 system achieved 97.5% first‐pass isolation with rapid, consistent procedural times. Further study of lesion durability and clinical outcomes is warranted.
- 30 January 2025
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 34 (3) , 253-265
Isochronal Apparent Dispersion at Early Activation Sites Accurately Identifies Outflow Tract Ventricular Ectopy Sites
- 30 January 2025
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 34 (3) , 253-265
Isochronal Apparent Dispersion at Early Activation Sites Accurately Identifies Outflow Tract Ventricular Ectopy Sites
- 31 October 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (11) , 2516-2539
Left Ventricular Summit Arrhythmias
- 31 October 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (11) , 2516-2539
Left Ventricular Summit Arrhythmias
- Open Access
- 16 September 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (11) , 2161-2172
Spontaneous termination of ventricular tachycardia in the human heart
Introduction: Understanding the spatiotemporal location of the spontaneous termination of ventricular tachycardia (VT) may provide new insights for ablation. To test the hypothesis that spontaneous VT termination most frequently occurs at the VT exit due to source‐sink mismatch and to characterize electrophysiological properties of the sites termination during VT and with extra‐stimulus technique.Methods: Retrospective analysis of intraoperative mapping studies of nine patients with ischemic cardiopathy or repaired tetralogy of Fallot. Simultaneous endocardial and epicardial mapping was performed in both ventricles using a custom mapping array during VT. Electrogram (EGM) characteristics before and at the moment of termination were analyzed including: cycle length oscillations, EGM heterogeneity and a variation in the systolic/diastolic path. The decrements to extra stimulus were analysed for termination sites and other diastolic sites.Results: Nine VTs in seven patients demonstrated spontaneous VT termination. Seven VTs (77.8%) spontaneously terminated in the final third of the systolic interval, one (11.1%) in early diastole and one (11.1%) in mid diastole. Cycle length oscillations (prolongation, shortening, and no change) were seen in equal frequency. Four VTs (44.4%) showed alternans in the local EGM at the site of termination and this was more prevalent than alternans at other sites in the diastolic pathway (p < .001). Only one‐third of VTs showed a change in activation pattern before termination. There was no difference based on etiology. During substrate characterization with extra‐stimulus pacing, sites of spontaneous termination showed greater decrement than other sites of the VT circuit during pacing (43.5 ± 14.5 ms vs. 31.2 ± 31.2 ms; p = .003).Conclusion: The entrance zone rather than the exit is the commonest site for the spontaneous termination of VT in the human heart. These sites tend to demonstrate EGM alternans during VT and greater decrement during extrastimulus pacing. These findings may help guide future studies into improving the success of VT ablation.
- 16 September 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (11) , 2161-2172
Open AccessSpontaneous termination of ventricular tachycardia in the human heart
Introduction: Understanding the spatiotemporal location of the spontaneous termination of ventricular tachycardia (VT) may provide new insights for ablation. To test the hypothesis that spontaneous VT termination most frequently occurs at the VT exit due to source‐sink mismatch and to characterize electrophysiological properties of the sites termination during VT and with extra‐stimulus technique.Methods: Retrospective analysis of intraoperative mapping studies of nine patients with ischemic cardiopathy or repaired tetralogy of Fallot. Simultaneous endocardial and epicardial mapping was performed in both ventricles using a custom mapping array during VT. Electrogram (EGM) characteristics before and at the moment of termination were analyzed including: cycle length oscillations, EGM heterogeneity and a variation in the systolic/diastolic path. The decrements to extra stimulus were analysed for termination sites and other diastolic sites.Results: Nine VTs in seven patients demonstrated spontaneous VT termination. Seven VTs (77.8%) spontaneously terminated in the final third of the systolic interval, one (11.1%) in early diastole and one (11.1%) in mid diastole. Cycle length oscillations (prolongation, shortening, and no change) were seen in equal frequency. Four VTs (44.4%) showed alternans in the local EGM at the site of termination and this was more prevalent than alternans at other sites in the diastolic pathway (p < .001). Only one‐third of VTs showed a change in activation pattern before termination. There was no difference based on etiology. During substrate characterization with extra‐stimulus pacing, sites of spontaneous termination showed greater decrement than other sites of the VT circuit during pacing (43.5 ± 14.5 ms vs. 31.2 ± 31.2 ms; p = .003).Conclusion: The entrance zone rather than the exit is the commonest site for the spontaneous termination of VT in the human heart. These sites tend to demonstrate EGM alternans during VT and greater decrement during extrastimulus pacing. These findings may help guide future studies into improving the success of VT ablation.
- 24 June 2024
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 67 (8) , 1749-1751
Novel use of surface isochronal dispersion mapping to identify source depth for focal ventricular ectopic catheter ablation
- 24 June 2024
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 67 (8) , 1749-1751
Novel use of surface isochronal dispersion mapping to identify source depth for focal ventricular ectopic catheter ablation
- 15 July 2023
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 34 (8) , 1787-1788
Two ripples in a pond: The subtleties of mapping observations in localizing premature ventricular complex sites
- 15 July 2023
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 34 (8) , 1787-1788
Two ripples in a pond: The subtleties of mapping observations in localizing premature ventricular complex sites
- Open Access
- 16 April 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (27) , 2447-2454
Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences
Background: Catheter ablation is an effective strategy in atrial fibrillation (AF). However, its timing in the course of management remains unclear. The aim of this study was to determine if an early vs. delayed AF ablation strategy is associated with differences in arrhythmia outcomes during 12-month follow-up. Methods and results: One hundred patients with symptomatic AF referred to a tertiary centre for management were randomized in a 1:1 ratio to either an early ablation strategy (within 1 month of recruitment) or a delayed ablation strategy (optimized medical therapy followed by catheter ablation at 12 months post recruitment). The primary endpoint was atrial arrhythmia free survival at 12 months post-ablation. Secondary outcomes included: (i) AF burden, (ii) AF burden by AF phenotype, and (iii) antiarrhythmic drug (AAD) use at 12 months. Overall, 89 patients completed the study protocol (Early vs. Delayed: 48 vs. 41). Mean age was 59 ± 12.9 years (29% women). Pulmonary vein isolation was achieved in 100% of patients. At 12 months, 56.3% of patients in the early ablation group were free from recurrent arrhythmia, compared with 58.6% in the delayed ablation group (HR 1.12, 95% CI 0.59–2.13, P = 0.7). All secondary outcomes showed no significant difference including median AF burden (Early vs. Delayed: 0% [IQR 3.2] vs. 0% [5], P = 0.66), median AF burden amongst paroxysmal AF patients (0% [IQR 1.1] vs. 0% [4.5], P = 0.78), or persistent AF patients (0% [IQR 22.8] vs. 0% [5.6], P = 0.45) or AAD use (33% vs. 37%, P = 0.8). Conclusion: Compared with an early ablation strategy, delaying AF ablation by 12 months for AAD management did not result in reduced ablation efficacy.
- 16 April 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (27) , 2447-2454
Open AccessImpact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences
Background: Catheter ablation is an effective strategy in atrial fibrillation (AF). However, its timing in the course of management remains unclear. The aim of this study was to determine if an early vs. delayed AF ablation strategy is associated with differences in arrhythmia outcomes during 12-month follow-up. Methods and results: One hundred patients with symptomatic AF referred to a tertiary centre for management were randomized in a 1:1 ratio to either an early ablation strategy (within 1 month of recruitment) or a delayed ablation strategy (optimized medical therapy followed by catheter ablation at 12 months post recruitment). The primary endpoint was atrial arrhythmia free survival at 12 months post-ablation. Secondary outcomes included: (i) AF burden, (ii) AF burden by AF phenotype, and (iii) antiarrhythmic drug (AAD) use at 12 months. Overall, 89 patients completed the study protocol (Early vs. Delayed: 48 vs. 41). Mean age was 59 ± 12.9 years (29% women). Pulmonary vein isolation was achieved in 100% of patients. At 12 months, 56.3% of patients in the early ablation group were free from recurrent arrhythmia, compared with 58.6% in the delayed ablation group (HR 1.12, 95% CI 0.59–2.13, P = 0.7). All secondary outcomes showed no significant difference including median AF burden (Early vs. Delayed: 0% [IQR 3.2] vs. 0% [5], P = 0.66), median AF burden amongst paroxysmal AF patients (0% [IQR 1.1] vs. 0% [4.5], P = 0.78), or persistent AF patients (0% [IQR 22.8] vs. 0% [5.6], P = 0.45) or AAD use (33% vs. 37%, P = 0.8). Conclusion: Compared with an early ablation strategy, delaying AF ablation by 12 months for AAD management did not result in reduced ablation efficacy.
- Open Access
- 27 March 2023
- Published by Elsevier in Indian Pacing and Electrophysiology Journal
- Vol. 23 (3) , 63-76
Utility of cardiac imaging in patients with ventricular tachycardia
- 27 March 2023
- Published by Elsevier in Indian Pacing and Electrophysiology Journal
- Vol. 23 (3) , 63-76
Open AccessUtility of cardiac imaging in patients with ventricular tachycardia
- Open Access
- 4 January 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (3) , 1172-1182
Orientation of conduction velocity vectors on cardiac mapping surfaces
Electroanatomical maps using automated conduction velocity (CV) algorithms are now being calculated using two-dimensional (2D) mapping tools. We studied the accuracy of mapping surface 2D CV, compared to the three-dimensional (3D) vectors, and the influence of mapping resolution in non-scarred animal and human heart models. Two models were used: a healthy porcine Langendorff model with transmural needle electrodes and a computer stimulation model of the ventricles built from an MRI-segmented, excised human heart. Local activation times (LATs) within the 3D volume of the mesh were used to calculate true 3D CVs (direction and velocity) for different pixel resolutions ranging between 500 μm and 4 mm (3D CVs). CV was also calculated for endocardial surface-only LATs (2D CV). In the experimental model, surface (2D) CV was faster on the epicardium (0.509 m/s) compared to the endocardium (0.262 m/s). In stimulation models, 2D CV significantly exceeded 3D CVs across all mapping resolutions and increased as resolution decreased. Three-dimensional and 2D left ventricle CV at 500 μm resolution increased from 429.2 ± 189.3 to 527.7 ± 253.8 mm/s (P < 0.01), respectively, with modest correlation (R = 0.64). Decreasing the resolution to 4 mm significantly increased 2D CV and weakened the correlation (R = 0.46). The majority of CV vectors were not parallel (<30°) to the mapping surface providing a potential mechanistic explanation for erroneous LAT-based CV over-estimation. Ventricular CV is overestimated when using 2D LAT-based CV calculation of the mapping surface and significantly compounded by mapping resolution. Three-dimensional electric field-based approaches are needed in mapping true CV on mapping surfaces. Leftward panel: Orientation vectors projecting from a basal view of the endocardium (blue, 3D true CV and pink, 2D CV). Top rightward panel: 3D and 2D CV vector parallel (30° in red). Bottom rightward panel: Distribution histogram showing increased 2D CV (pink) compared to the 3D CV (blue). 2D, two-dimensional; 3D, three-dimensional; CV, conduction velocity; EAM, electroanatomical mapping; EGM, electrogram; LAT, local activation time; LV, left ventricle; RV, right ventricle; VT, ventricular tachycardia
- 4 January 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (3) , 1172-1182
Open AccessOrientation of conduction velocity vectors on cardiac mapping surfaces
Electroanatomical maps using automated conduction velocity (CV) algorithms are now being calculated using two-dimensional (2D) mapping tools. We studied the accuracy of mapping surface 2D CV, compared to the three-dimensional (3D) vectors, and the influence of mapping resolution in non-scarred animal and human heart models. Two models were used: a healthy porcine Langendorff model with transmural needle electrodes and a computer stimulation model of the ventricles built from an MRI-segmented, excised human heart. Local activation times (LATs) within the 3D volume of the mesh were used to calculate true 3D CVs (direction and velocity) for different pixel resolutions ranging between 500 μm and 4 mm (3D CVs). CV was also calculated for endocardial surface-only LATs (2D CV). In the experimental model, surface (2D) CV was faster on the epicardium (0.509 m/s) compared to the endocardium (0.262 m/s). In stimulation models, 2D CV significantly exceeded 3D CVs across all mapping resolutions and increased as resolution decreased. Three-dimensional and 2D left ventricle CV at 500 μm resolution increased from 429.2 ± 189.3 to 527.7 ± 253.8 mm/s (P < 0.01), respectively, with modest correlation (R = 0.64). Decreasing the resolution to 4 mm significantly increased 2D CV and weakened the correlation (R = 0.46). The majority of CV vectors were not parallel (<30°) to the mapping surface providing a potential mechanistic explanation for erroneous LAT-based CV over-estimation. Ventricular CV is overestimated when using 2D LAT-based CV calculation of the mapping surface and significantly compounded by mapping resolution. Three-dimensional electric field-based approaches are needed in mapping true CV on mapping surfaces. Leftward panel: Orientation vectors projecting from a basal view of the endocardium (blue, 3D true CV and pink, 2D CV). Top rightward panel: 3D and 2D CV vector parallel (30° in red). Bottom rightward panel: Distribution histogram showing increased 2D CV (pink) compared to the 3D CV (blue). 2D, two-dimensional; 3D, three-dimensional; CV, conduction velocity; EAM, electroanatomical mapping; EGM, electrogram; LAT, local activation time; LV, left ventricle; RV, right ventricle; VT, ventricular tachycardia